A 58-year-old man from Delhi with a 12-year history of Type 2 diabetes mellitus presents with progressive fatigue and dyspnea on exertion. His HbA1c is 8.9% despite metformin and glibenclamide therapy. Fasting blood glucose is 165 mg/dL. On examination, he has central obesity (waist circumference 105 cm), hypertension (148/92 mmHg), and mild peripheral edema. Serum creatinine is 1.8 mg/dL (eGFR 38 mL/min/1.73m²), and urinary albumin-to-creatinine ratio (UACR) is 320 mg/g. Fundoscopy reveals dot-blot hemorrhages and hard exudates. What is the primary pathological lesion in the kidney that accounts for his albuminuria?

Explanation

## Pathological Diagnosis: Diabetic Nephropathy with Nodular Glomerulosclerosis ### Clinical Context **Key Point:** This patient has Type 2 DM with microvascular complications (retinopathy, nephropathy) and metabolic syndrome features (central obesity, hypertension). The UACR of 320 mg/g indicates **albuminuria in the nephrotic range** (>300 mg/g), and reduced eGFR shows progressive renal dysfunction. ### Pathological Stages of Diabetic Nephropathy | Stage | Pathology | Functional Changes | UACR | | --- | --- | --- | --- | | **1** | Glomerular hyperfiltration, basement membrane thickening | Increased GFR | <30 mg/g | | **2** | Nodular glomerulosclerosis (Kimmelstiel-Wilson) | Microalbuminuria onset | 30–300 mg/g | | **3** | Diffuse glomerulosclerosis + interstitial changes | Progressive albuminuria | >300 mg/g | | **4** | Advanced sclerosis + tubular atrophy + fibrosis | ESRD | Variable | **High-Yield:** The **Kimmelstiel-Wilson lesion** (nodular glomerulosclerosis) is **pathognomonic for Type 2 diabetic nephropathy**. It consists of: - **Nodular accumulations of PAS-positive material** (basement membrane proteins, collagen IV, laminin) - **Surrounded by patent capillary loops** (distinguishes it from diffuse sclerosis) - Located in the **glomerular mesangium** ### Mechanism of Nodular Glomerulosclerosis ```mermaid flowchart TD A["Chronic Hyperglycemia"]:::outcome --> B["Increased Glucose Flux via Sorbitol Pathway"]:::action B --> C["AGE Formation & PKC Activation"]:::action C --> D["Increased TGF-β & CTGF"]:::action D --> E["Mesangial Cell Proliferation & ECM Deposition"]:::action E --> F["Nodular Glomerulosclerosis"]:::outcome A --> G["Glomerular Basement Membrane Thickening"]:::outcome G --> H["Loss of Charge Selectivity"]:::action H --> I["Albuminuria"]:::outcome ``` ### Pathological Features in This Patient **Key Point:** The combination of: 1. **Retinopathy** (dot-blot hemorrhages, hard exudates) — indicates concurrent microvascular disease 2. **Albuminuria >300 mg/g** — nephrotic-range proteinuria 3. **Reduced eGFR (38)** — Stage 3b CKD 4. **Long duration of diabetes (12 years)** — sufficient time for nodular lesions to develop ...all point to **advanced diabetic nephropathy with Kimmelstiel-Wilson lesions**. ### Histopathology (Light Microscopy) **Clinical Pearl:** On kidney biopsy (if performed): - **PAS-positive, diastase-resistant nodules** in the glomerular mesangium - **Basement membrane thickening** (up to 2–3× normal) - **Diffuse mesangial expansion** between nodules - **Hyaline arteriolosclerosis** in afferent and efferent arterioles - **Interstitial fibrosis and tubular atrophy** (late stage) ### Electron Microscopy - **Thickened glomerular basement membrane** (>400 nm; normal ~300 nm) - **Effacement of podocyte foot processes** (explains albuminuria) - **Nodular electron-dense deposits** (not immune complex-mediated) ### Why Albuminuria Occurs 1. **Loss of charge selectivity** — basement membrane thickening and nodular sclerosis disrupt the negative charge barrier 2. **Loss of size selectivity** — increased pore size allows albumin passage 3. **Reduced podocyte integrity** — foot process effacement impairs filtration barrier **Mnemonic: KIMMELSTIEL-WILSON = Kidney nodules in diabetic patients (Type 2 > Type 1)**